A Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of BR2021 and BR2021-1

Clinical trial NCT06867497 · RECRUITING

Trial details

NCT number: NCT06867497
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Adenocarcinoma of the Pancreas

Start date: 2025-02-24
Primary completion: 2025-10-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.